help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on October 25, 2007, doi:10.1164/rccm.200612-1759OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200612-1759OCv1
177/2/190    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoniou, K. M.
Right arrow Articles by Wells, A. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoniou, K. M.
Right arrow Articles by Wells, A. U.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 190-194, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200612-1759OC

Original Article

Idiopathic Pulmonary Fibrosis

Outcome in Relation to Smoking Status

Katerina M. Antoniou1,2, David M. Hansell3, Michael B. Rubens3, Katharina Marten3, Sujal R. Desai4, Nikolaos M. Siafakas2, Andrew G. Nicholson5, Roland M. du Bois1 and Athol U. Wells1

1 Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom; 2 Department of Thoracic Medicine, University of Crete, Heraklion, Greece; 3 Department of Radiology, Royal Brompton Hospital, London, United Kingdom; 4 Department of Radiology, King's College Hospital, London, United Kingdom; and 5 Department of Histopathology, Royal Brompton Hospital, London, United Kingdom

Correspondence and requests for reprints should be addressed to Athol U. Wells, M.D., Interstitial Lung Disease Unit, c/o Emmanuel Kaye Building, Manresa Road, London SW3 6LR, UK. E-mail: a.wells{at}rbh.nthames.nhs.uk

Rationale: The pathogenic importance of smoking status in idiopathic pulmonary fibrosis (IPF) is uncertain. In theory, increased oxidative stress in current and former smokers might promote disease progression. However, better survival has been reported for current smokers with IPF, although this might reflect less severe disease at presentation (a "healthy smoker effect").

Objectives: To determine whether smoking status is associated with survival differences in IPF.

Methods: A total of 249 patients with IPF were studied (current smokers, n = 20; former smokers, n = 166; never-smokers, n = 63). Survival was evaluated against smoking status, using proportional hazards analysis, adjusting for sex, age, disease severity (extent of the disease on high-resolution computed tomography, composite physiologic index [CPI], percentage predicted diffusing capacity for carbon monoxide in separate models), and the degree of honeycombing.

Measurements and Main Results: Current smokers had milder disease than did former smokers, with lower CPI scores (P < 0.0001), less extensive disease on high-resolution computed tomography (P < 0.005), and higher unadjusted survival (hazard ratio = 0.44; 95% confidence interval = 0.24, 0.80; P = 0.007). However, survival did not differ between current and former smokers (P = 0.39) after adjustment for CPI levels. By contrast, the increase in survival seen in nonsmokers than in former smokers (hazard ratio = 0.51; 95% confidence interval = 0.41, 0.83; P = 0.008) was amplified (P < 0.0005) by adjustment for CPI levels.

Conclusions: In IPF, survival and severity-adjusted survival are higher in nonsmokers than in former smokers or the combined group of former and current smokers. By contrast, a better outcome in current smokers, compared with former smokers, reflects less severe disease at presentation and may represent a healthy smoker effect.

Key Words: idiopathic pulmonary fibrosis • cigarette smoking • outcome • survival


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
In idiopathic pulmonary fibrosis (IPF), survival is higher in nonsmokers than in smokers. By contrast, a better outcome in current smokers, compared with former smokers, reflects less severe disease at presentation and thus represents a "healthy smoker effect."

What This Study Adds to the Field
In IPF, survival and severity-adjusted survival are higher in nonsmokers than in former smokers or the combined group of former and current smokers. Our major finding is the negative influence of cigarette smoking on IPF outcome.

 



This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
D. S. Wilkes
Clinical Year in Review III: Idiopathic Pulmonary Fibrosis, Occupational Medicine, and Lung Transplantation
Proceedings of the ATS, September 15, 2008; 5(7): 751 - 754.
[Full Text] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
G. Braganza, R. Chaudhuri, and N. C. Thomson
Review: Treating patients with respiratory disease who smoke
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society 		  Solid Organ Transplant for the Intensivist 2008